Compare MDXH & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDXH | FOFO |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | Belgium | Hong Kong |
| Employees | N/A | 14 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1M | 19.0M |
| IPO Year | 2021 | N/A |
| Metric | MDXH | FOFO |
|---|---|---|
| Price | $0.48 | $3.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 772.9K | 152.4K |
| Earning Date | 05-14-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.78 | N/A |
| Revenue Next Year | $18.31 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $1.75 |
| 52 Week High | $5.33 | $68.00 |
| Indicator | MDXH | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 33.26 | 47.94 |
| Support Level | N/A | $2.55 |
| Resistance Level | $3.79 | $5.74 |
| Average True Range (ATR) | 0.06 | 0.46 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 47.66 | 18.69 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.